CARD15/NOD2, CD14 and toll-like 4 receptor gene polymorphisms in saudi patients with crohn's disease

International Journal of Molecular Sciences

Volumn 13, Issue 4, 2012, Pages 4268-4280

  Azzam, Nahla ^a   Nounou, Howaida ^b   Alharbi, Othman ^a   Aljebreen, Abedulrahman ^a   Shalaby, Manal ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

CARD15 NOD2; Crohn's disease; Genetic polymorphism; Inflammatory bowel disease

Indexed keywords

ADALIMUMAB; ARGININE; AZATHIOPRINE; BUDESONIDE; CD14 ANTIGEN; CYTOSINE; GLYCINE; INFLIXIMAB; LEUCINE; MESALAZINE; STEROID; THREONINE; THYMINE; TOLL LIKE RECEPTOR 4; TRYPTOPHAN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; NOD2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CARD15 GENE; CD14 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DNA POLYMORPHISM; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MALE; MUTANT; NOD2 GENE; POPULATION GENETICS; POPULATION RESEARCH; PROMOTER REGION; SAUDI; TOLL LIKE 4 RECEPTOR GENE; ADOLESCENT; ALLELE; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SAUDI ARABIA; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALLELES; ANTIGENS, CD14; CROHN DISEASE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SAUDI ARABIA; TOLL-LIKE RECEPTOR 4; YOUNG ADULT;

EID: 84860147810     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13044268     Document Type: Article

References (30)

1. Podolsky, D.K. Inflammatory bowel disease. N. Engl. J. Med. 2002, 347, 417-429.
2. Lesage, S.; Zouali, H.; Cezard, J.P.; Colombel, J.F.; Belaiche, J.; Almer, S.; Tysk, C.; O'Morain, C.; Gassull, M.; Binder, V.; et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am. J. Hum. Genet. 2002, 70, 845-857.
3. Gutierrez, O.; Pipaon, C.; Inohara, N.; Fontalba, A.; Ogura, Y.; Prosper, F.; Nunez, G.; Fernandez-Luna, J.L. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J. Biol. Chem. 2002, 277, 41701-41705.
4. Hugot, J.P.; Cezard, J.P.; Colombel, J.F.; Belaiche, J.; Almer, S.; Tysk, C.; Montague, S.; Gassull, M.; Christensen, S.; Finkel, Y.; et al.Clustering of Crohn's disease within affected sibships. Eur. J. Hum. Genet. 2003, 11, 179-184.
5. Rosenstiel, P.; Fantini, M.; Brautigam, K.; Kuhbacher, T.; Waetzig, G.H.; Seegert, D.; Schreiber, S. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 2003, 124, 1001-1009.
6. Bonen, D.K.; Ogura, Y.; Nicolae, D.L.; Inohara, N.; Saab, L.; Tanabe, T.; Chen, F.F.; Foster, S.J.; Duerr, R.H.; Brant, S.R.; et al. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 2003, 124, 140-146.
7. Yamazaki, K.; Takazoe, M.; Tanaka, T.; Kazumori, T.; Nakamura, Y. Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J. Hum. Genet. 2002, 47, 469-472.
8. Wang, Z.W.; Ji, F.; Teng, W.J.; Yuan, X.G.; Ye, X.M. Risk factors and gene polymorphisms of inflammatory bowel disease in population of Zhejiang, China. World J. Gastroenterol. 2011, 17, 118-122.
9. Arbour, N.C.; Lorenz, E.; Schutte, B.C.; Zabner, J.; Kline, J.N.; Jones, M.; Frees, K.; Janet, L. Watt, J.L.; Schwartz, D.A. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 2000, 25, 187-191.
10. Brand, S.; Staudinger, T.; Schnitzler, F.; Pfennig, S.; Hofbauer, K.; Dambacher, J.; Seiderer, J.; Tillack, C.; Konrad, A.; Crispin, A.; et al. The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease. Inflamm. Bowel. Dis. 2005, 11, 645-652.
11. Gazouli, M.; Mantzaris, G.; Kotsinas, A.; Zacharatos, P.; Papalambros, E.; Archimandritis, A.; Ikonomopoulos, J.; Gorgoulis, V.G. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J. Gastroenterol. 2005, 11, 681-685.
12. Barton, G.M.; Medzhitov, R. Toll-like receptor signaling pathways. Science 2003, 300, 1524-1525.
13. Klein, W.; Tromm, A.; Griga, T.; Folwaczny, C.; Hocke, M.; Eitner, K.; Marx, M.; Duerig, N.; Epplen, J.T. Interaction of polymorphisms in the CARD15 and CD14 genes in patients with Crohn disease. Scand. J. Gastroenterol. 2003, 38, 834-836.
14. Rioux, J.D.; Silverberg, M.S.; Daly, M.J.; Steinhart, A.H.; McLeod, R.S.; Griffiths, A.M.; Green, T.; Brettlin, T.S.; Stone, V.; Bull, S.B.; et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am. J. Hum. Genet. 2000, 66, 1863-1870.
15. Grimm, M.C.; Pavli, P.; van de Pol, E.; Doe, W.F. Evidence for a CD14+ population of monocytes in inflammatory bowel disease mucosa-implications for pathogenesis. Clin. Exp. Immunol. 1995, 100, 291-297.
16. Zouiten-Mekki, L.; Zaouali, H.; Boubaker, J.; Karoui, S.; Fekih, M.; Matri, S.; Hamzaoui, S.; Filali, A.; Chaabouni, H.; Hugot, J.P. CARD15/NOD2 in a Tunisian population with Crohn's disease. Dig. Dis. Sci. 2005, 50, 130-135.
17. Karban, A.; Waterman, M.; Panhuysen, C.I.; Pollak, R.D.; Nesher, S.; Datta, L.; Weiss, B.; Suissa, A.; Shamir, R.; Brant, S.R.; et al. NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease. Am. J. Gastroenterol. 2004, 99, 1134-1140.
18. Tukel, T.; Shalata, A.; Present, D.; Rachmilewitz, D.; Mayer, L.; Grant, D.; Risch, N.; Desnick, R.J. Crohn disease: Frequency and nature of CARD15 mutations in Ashkenazi and Sephardi/Oriental Jewish families. Am. J. Hum. Genet. 2004, 74, 623-636.
19. Cuthbert, A.P.; Fisher, S.A.; Mirza, M.M.; King, K.; Hampe, J.; Croucher, P.J.; Mascheretti, S.; Sanderson, J.; Forbes, A.; Mansfield, J.; et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002, 122, 867-874.
20. Barbujani, G.; Bertorelle, G. Genetics and the population history of Europe. Proc. Natl. Acad. Sci. USA 2001, 98, 22-25.
21. Mohamed, J.A.; DuPont, H.L.; Flores, J.; Palur, H.; Nair, P.; Jiang, Z.D.; Guo, D.; Belkind-Gerson, J.; Okhuysen, P.C. Single nucleotide polymorphisms in the promoter of the gene encoding the lipopolysaccharide receptor CD14 are associated with bacterial diarrhea in US and Canadian travelers to Mexico. Clin. Infect. Dis. 2011, 52, 1332-1341.
22. Franchimont, D.; Vermeire, S.; El Housni, H.; Pierik, M.; van Steen, K.; Gustot, T.; Quertinmont, E.; Abramowicz, M.; van Gossum, A.; Deviere, J.; et al. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 2004, 53, 987-992.
23. Torok, H.P.; Glas, J.; Tonenchi, L.; Mussack, T.; Folwaczny, C. Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: Association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. Clin. Immunol. 2004, 112, 85-91.
24. Agnese, D.M.; Calvano, J.E.; Hahm, S.J.; Coyle, S.M.; Corbett, S.A.; Calvano, S.E.; Lowry, S.F. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J. Infect. Dis. 2002, 186, 1522-1525.
25. Lakatos, P.L.; Lakatos, L.; Szalay, F.; Willheim-Polli, C.; Osterreicher, C.; Tulassay, Z.; Molnar, T.; Reinisch, W.; Papp, J.; Mozsik, G.; et al. Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: Phenotype-genotype correlations. World J. Gastroenterol. 2005, 11, 1489-1495.
26. Zouiten-Mekki, L.; Kharrat, M.; Karoui, S.; Serghimi, M.; Fekih, M.; Matri, S.; Kallel, L.; Boubaker, J.; Filali, A.; Chaabouni, H. Toll like receptor 4 (TLR4) polymorphisms in Tunisian patients with Crohn's disease: Genotype-phenotype correlation. BMC Gastroenterol. 2009, 9, doi:10.1186/1471-230X-9-62.
27. Arnott, I.D.; Nimmo, E.R.; Drummond, H.E.; Fennell, J.; Smith, B.R.; MacKinlay, E.; Morecroft, J.; Anderson, N.; Kelleher, D.; O'Sullivan, M.; et al. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: Evidence for genetic heterogeneity within Europe? Genes Immun. 2004, 5, 417-425.
28. Oostenbrug, L.E.; Drenth, J.P.; de Jong, D.J.; Nolte, I.M.; Oosterom, E.; van Dullemen, H.M.; van der Linde, K.; te Meerman, G.J.; van der Steege, G.; Jan H Kleibeuker, J.H.; et al. Association between Toll-like receptor 4 and inflammatory bowel disease. Inflamm. Bowel Dis. 2005, 11, 567-575.
29. Canto, E.; Ricart, E.; Busquets, D.; Monfort, D.; Garcia-Planella, E.; Gonzalez, D.; Balanzo, J.; Rodriguez-Sanchez, J.L.; Vidal, S. Influence of a nucleotide oligomerization domain 1 (NOD1) polymorphism and NOD2 mutant alleles on Crohn's disease phenotype. World J. Gastroenterol. 2007, 13, 5446-5453.
30. Nunez, C.; Barreiro, M.; Dominguez-Munoz, J.E.; Lorenzo, A.; Zapata, C.; Pena, A.S. CARD15 mutations in patients with Crohn's disease in a homogeneous Spanish population. Am. J. Gastroenterol. 2004, 99, 450-456.